Heart Failure

Carew Medical Wear, Rod Carew, undergarments, LVAD, HeartMate II, American Heart Association
News | Ventricular Assist Devices (VAD) | August 11, 2016
August 11, 2016 — Carew Medical Wear Inc., a custom medical outfit company specializing in...
ICU use for heart failure
News | Heart Failure | August 09, 2016
August 9, 2016 – With the use of intensive care units (ICUs) on the rise in many hospitals, researchers at LA BioMed...
CardioKinetix, Parachute device, heart failure, 500th implantation, PARACHUTE IV Trial
News | Heart Failure | July 22, 2016
July 22, 2016 — CardioKinetix Inc. announced this week that 500 patients have received the company’s Parachute...
University of Guelph study, heart failure risk, gender, aging
News | Heart Failure | July 08, 2016
July 8, 2016 — University of Guelph researchers have uncovered a possible clue as to why women have lower rates of...
SynCardia acquired, Versa Capital Management, chapter 11
News | Business | July 07, 2016
July 7, 2016 — SynCardia Systems Inc. announced that it has entered into an...
News | Heart Failure | July 05, 2016
July 5, 2016 — A research team has developed a new electric mesh device that can be wrapped around the heart to deliver...
HeartWare, HVAD, batteries recall
News | Ventricular Assist Devices (VAD) | July 05, 2016
July 5, 2016 — HeartWare Inc. announced a recall of the batteries used on the...
BioVentrix, Revivent-TC, transcatheter heart failure system, CE Mark
News | Heart Failure | June 30, 2016
June 30, 2016 — BioVentrix Inc. announced that it has received certification for CE marking its Revivent TC...
beta-blockers, Thomas Jefferson University, beta-adrenergic receptors

Selective activation of the beta2-adrenergic receptor (beta2AR) by a beta-arrestin-biased pepducin promotes activation of a beta-arrestin signaling pathway that is cardioprotective. Image courtesy of the lab of Jeffrey Benovic, Thomas Jefferson University.

News | Heart Failure | June 30, 2016
June 30, 2016 — Researchers at Thomas Jefferson University have discovered how to enhance the effectiveness of beta-...
Videos | Cardio-oncology | June 30, 2016
Interview with Federico Asch, M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health...
St. Jude Medical, HeartMate 3 LVAS, LVAD, CardioStim-EHRA Europace Innovation Award 2016
News | Ventricular Assist Devices (VAD) | June 29, 2016
June 29, 2016 — St. Jude Medical Inc. recently announced the company received an Innovation Award for its HeartMate 3...
St. Jude Medical, CE Mark, SyncAV CRT, MultiPoint Pacing, CardioStim 2016
Technology | Cardiac Resynchronization Therapy Devices (CRT) | June 28, 2016
June 28, 2016 — St. Jude Medical Inc. announced CE Mark approval and launch of SyncAV CRT software, designed to build...
Allied Market Research, Congestive Heart Failure Treatment Devices Market report, ICDshea
News | Heart Failure | June 28, 2016
June 28, 2016 — A recent report published by Allied Market Research, titled, "Congestive Heart Failure (CHF) Treatment...
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Clinical Study | June 28, 2016
June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom...
heart failure, muscle bleeding, British Cardiovascular Conference, MRI
News | Heart Failure | June 08, 2016
June 8, 2016 — The amount a heart ‘bleeds’ following a heart attack can predict the severity of future...
Overlay Init